A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy
{{output}}
Chimeric antigen receptor (CAR) T cells have transformed hematologic cancer therapy but remain limited in solid tumors by antigen heterogeneity and a suppressive, pro-fibrotic microenvironment. We previously identified the urokinase plasminogen activator recep... ...
